Diseases investigated in the second phase

Diseases investigated in the second phase:

• Phase 2-A: 1000 hereditary neurological or skin or blood hereditary
• Phase 2-B: 500 hereditary neurological or skin or blood hereditary patients who do not have phase 2-A mutations.